BioCentury
ARTICLE | Clinical News

VerifyNow P2Y12 assay: Pivotal trial data

December 6, 2010 8:00 AM UTC

The double-blind, placebo-controlled, North American pivotal GRAVITAS trial in 2,214 evaluable patients with high residual platelet reactivity as measured by Accumetrics' VerifyNow P2Y12 assay after P...